Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ignacio Rodriguez

Showing results (231-240 of 254) with videos related to

Pageof 26
Sort By:
American Heart Journal|June 20, 2018
The Second Annual Think Tank on Prevention of Sudden Cardiac Death in the Young: Developing a rational, reliable, and sustainable national health care resource. A report from the Cardiac Safety Research ConsortiumPeter F Aziz, Stuart Berger, Peter Kowey, et al.
Journal of Cellular Physiology|January 18, 2018
Recombinant human hepatocyte growth factor provides protective effects in cerulein-induced acute pancreatitis in miceMayrel Palestino-Dominguez, Mario Pelaez-Luna, Roberto Lazzarini-Lechuga, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 16, 2021
p53 regulation by MDM2 contributes to self-renewal and differentiation of basal stem cells in mouse and human airway epitheliumSergio Garrido-Jimenez, Juan Francisco Barrera-Lopez, Selene Diaz-Chamorro, et al.
American Heart Journal|June 15, 2016
The Cardiac Safety Research Consortium enters its second decade: An invitation to participateJ Rick Turner, Peter R Kowey, Ignacio Rodriguez, et al.
Journal of Molecular Medicine (Berlin, Germany)|September 25, 2014
Transducin-like enhancer of split 3 (TLE3) in adipose tissue is increased in situations characterized by decreased PPARγ gene expressionFrancisco José Ortega, Marta Serrano, Sergio Rodriguez-Cuenca, et al.
American Heart Journal|March 30, 2013
The evaluation and management of drug effects on cardiac conduction (PR and QRS intervals) in clinical developmentAdel Nada, Gary A Gintant, Robert Kleiman, et al.
American Heart Journal|July 12, 2011
Troponin measurements during drug development--considerations for monitoring and management of potential cardiotoxicity: an educational collaboration among the Cardiac Safety Research Consortium, the Duke Clinical Research Institute, and the US Food and Drug AdministrationL Kristin Newby, Ignacio Rodriguez, John Finkle, et al.
Journal of the American College of Cardiology|October 12, 2019
Long-Term Dabigatran Treatment Delays Alzheimer's Disease Pathogenesis in the TgCRND8 Mouse ModelMarta Cortes-Canteli, Anna Kruyer, Irene Fernandez-Nueda, et al.
American Heart Journal|April 21, 2009
Assessing proarrhythmic potential of drugs when optimal studies are infeasibleEdwin P Rock, John Finkle, Howard J Fingert, et al.
American Heart Journal|October 12, 2010
Electrocardiographic assessment for therapeutic proteins--scientific discussionIgnacio Rodriguez, Andrew Erdman, Desmond Padhi, et al.
Pageof 26

Showing results (231-240 of 254) with videos related to

Sort By:
Pageof 26
American Heart Journal|June 20, 2018
The Second Annual Think Tank on Prevention of Sudden Cardiac Death in the Young: Developing a rational, reliable, and sustainable national health care resource. A report from the Cardiac Safety Research ConsortiumPeter F Aziz, Stuart Berger, Peter Kowey, et al.
Journal of Cellular Physiology|January 18, 2018
Recombinant human hepatocyte growth factor provides protective effects in cerulein-induced acute pancreatitis in miceMayrel Palestino-Dominguez, Mario Pelaez-Luna, Roberto Lazzarini-Lechuga, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 16, 2021
p53 regulation by MDM2 contributes to self-renewal and differentiation of basal stem cells in mouse and human airway epitheliumSergio Garrido-Jimenez, Juan Francisco Barrera-Lopez, Selene Diaz-Chamorro, et al.
American Heart Journal|June 15, 2016
The Cardiac Safety Research Consortium enters its second decade: An invitation to participateJ Rick Turner, Peter R Kowey, Ignacio Rodriguez, et al.
Journal of Molecular Medicine (Berlin, Germany)|September 25, 2014
Transducin-like enhancer of split 3 (TLE3) in adipose tissue is increased in situations characterized by decreased PPARγ gene expressionFrancisco José Ortega, Marta Serrano, Sergio Rodriguez-Cuenca, et al.
American Heart Journal|March 30, 2013
The evaluation and management of drug effects on cardiac conduction (PR and QRS intervals) in clinical developmentAdel Nada, Gary A Gintant, Robert Kleiman, et al.
American Heart Journal|July 12, 2011
Troponin measurements during drug development--considerations for monitoring and management of potential cardiotoxicity: an educational collaboration among the Cardiac Safety Research Consortium, the Duke Clinical Research Institute, and the US Food and Drug AdministrationL Kristin Newby, Ignacio Rodriguez, John Finkle, et al.
Journal of the American College of Cardiology|October 12, 2019
Long-Term Dabigatran Treatment Delays Alzheimer's Disease Pathogenesis in the TgCRND8 Mouse ModelMarta Cortes-Canteli, Anna Kruyer, Irene Fernandez-Nueda, et al.
American Heart Journal|April 21, 2009
Assessing proarrhythmic potential of drugs when optimal studies are infeasibleEdwin P Rock, John Finkle, Howard J Fingert, et al.
American Heart Journal|October 12, 2010
Electrocardiographic assessment for therapeutic proteins--scientific discussionIgnacio Rodriguez, Andrew Erdman, Desmond Padhi, et al.
Pageof 26